Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/30755240http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/30755240http://www.w3.org/2000/01/rdf-schema#comment"

Background

Human gliomas are highly fatal tumors with a significant feature of immune suppression. The association of the immune system in gliomas is gradually revealed, and immunotherapy is expected to improve the survival of glioma patients. In-depth understanding of the immune microenvironment of gliomas and their associated immunotherapy was increased exponentially in recent years. Gliomas provide clinical targets for immunotherapy during the search of key regulators of immune response. Our study focused on the human leukocyte antigen (HLA) system that is responsible for regulating the immune system, and discovered the relationship between HLA-F expression and clinical prognosis in gliomas.

Methods

A total of 593 patients with gliomas were included in our research. Of these, 325 patients were from the Chinese Glioma Genome Atlas (CGGA) and 268 were from the GSE 16011 set. Kaplan-Meier (KM) analysis was performed to explore the prognostic value of HLA-F. t test analysis was used to find the distribution difference in various groups. R language packages are used for other statistical computations and figure drawing.

Results

HLA-F was negatively correlated with overall survival (OS) in all grades of glioma and glioblastoma (GBM). Moreover, HLA-F was enriched in GBM and isocitrate dehydrogenase 1 wild-type (IDH1 wt) group and considered HLA-F as a mesenchymal subtype marker. Pearson correlation test showed that HLA-F was correlated with other HLA-I molecules.

Conclusion

HLA-F expression was positively correlated with malignant phenotype and negatively correlated with OS, indicating that HLA-F could predict the immune state of gliomas and might be a clinical target of glioma immunotherapy."xsd:string
http://purl.uniprot.org/citations/30755240http://purl.org/dc/terms/identifier"doi:10.1186/s12974-019-1418-3"xsd:string
http://purl.uniprot.org/citations/30755240http://purl.uniprot.org/core/author"Du J."xsd:string
http://purl.uniprot.org/citations/30755240http://purl.uniprot.org/core/author"Wang F."xsd:string
http://purl.uniprot.org/citations/30755240http://purl.uniprot.org/core/author"Wang X."xsd:string
http://purl.uniprot.org/citations/30755240http://purl.uniprot.org/core/author"Wang X.'"xsd:string
http://purl.uniprot.org/citations/30755240http://purl.uniprot.org/core/author"Tang K."xsd:string
http://purl.uniprot.org/citations/30755240http://purl.uniprot.org/core/author"Liang T."xsd:string
http://purl.uniprot.org/citations/30755240http://purl.uniprot.org/core/author"You G."xsd:string
http://purl.uniprot.org/citations/30755240http://purl.uniprot.org/core/author"Feng E."xsd:string
http://purl.uniprot.org/citations/30755240http://purl.uniprot.org/core/date"2019"xsd:gYear
http://purl.uniprot.org/citations/30755240http://purl.uniprot.org/core/name"J Neuroinflammation"xsd:string
http://purl.uniprot.org/citations/30755240http://purl.uniprot.org/core/pages"33"xsd:string
http://purl.uniprot.org/citations/30755240http://purl.uniprot.org/core/title"Correlation of alteration of HLA-F expression and clinical characterization in 593 brain glioma samples."xsd:string
http://purl.uniprot.org/citations/30755240http://purl.uniprot.org/core/volume"16"xsd:string
http://purl.uniprot.org/citations/30755240http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/30755240
http://purl.uniprot.org/citations/30755240http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/30755240
http://purl.uniprot.org/uniprot/#_A0A346MPT4-mappedCitation-30755240http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/30755240
http://purl.uniprot.org/uniprot/#_A0A3G2C0L7-mappedCitation-30755240http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/30755240
http://purl.uniprot.org/uniprot/#_A0A1V0E3T9-mappedCitation-30755240http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/30755240
http://purl.uniprot.org/uniprot/#_A0A1V0E3U0-mappedCitation-30755240http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/30755240
http://purl.uniprot.org/uniprot/#_A0A1V0E3U1-mappedCitation-30755240http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/30755240
http://purl.uniprot.org/uniprot/#_A0A1V0E3U3-mappedCitation-30755240http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/30755240
http://purl.uniprot.org/uniprot/#_A0A1V0E3V1-mappedCitation-30755240http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/30755240
▶